...
首页> 外文期刊>Medical science monitor : >Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
【24h】

Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.

机译:血浆纤维蛋白原,D-二聚体和von Willebrand因子作为慢性血液透析患者心血管疾病的标志物的有效性。

获取原文

摘要

Background: Among the non-classic cardiovascular disease risk factors inend-stage renal disease patients on chronic hemodialysis (HD), plasma fibrinogen, D-dimer, and von Willebrandfactor (vWf) levels are potential markers of cardiovascular morbidity. We designed this case-controlstudy to investigate their validity and any differences between them. Material/Methods: Twenty-five HDpatients (18 males, mean age: 63, range: 52-69 years) comprised the group with prevalent cardiovasculardisease (CVD) and 50 HD patients (35 males, mean age: 62, range: 40-77 years) with non-evident cardiovasculardisease history constituted the second study group. Twenty-five healthy non-smoking volunteers servedas controls for comparison with the study groups. Results: Patients with CVD had significantly higherconcentrations of plasma fibrinogen, D-dimer, and vWf than patients without incident CVD. All three parameterscorrelated positively with cardiovascular morbidity, i.e. fibrinogen (r=0.378, [i]P[/i]0.001), logDD (r=0.70,[i]P[/i]
机译:背景:在慢性血液透析(HD)晚期肾病患者的非经典心血管疾病危险因素中,血浆纤维蛋白原,D-二聚体和von Willebrandfactor(vWf)水平是心血管疾病发病的潜在标志。我们设计了这种病例对照研究来调查其有效性以及它们之间的任何差异。材料/方法:25位HD患者(18例男性,平均年龄:63,范围:52-69岁)包括患心血管疾病(CVD)的组和50例HD患者(35例男性,平均年龄:62,范围:40- 77岁)具有明显的心血管疾病史构成第二研究组。 25名健康的非吸烟志愿者作为对照,与研究组进行比较。结果:CVD患者的血浆纤维蛋白原,D-二聚体和vWf的浓度明显高于未发生CVD的患者。这三个参数均与心血管疾病的发病率正相关,即纤维蛋白原(r = 0.378,[i] P [/ i] 0.001),logDD(r = 0.70,[i] P [/ i]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号